The state and consequences of dermatology drug prices in the United States

J Am Acad Dermatol. 2016 Sep;75(3):603-605. doi: 10.1016/j.jaad.2016.03.053. Epub 2016 Jul 13.

¹ Department of Dermatology, Rush Medical College, Chicago, Illinois.
² Department of Dermatology, Mount Sinai School of Medicine, New York, New York.
³ Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
⁴ Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
⁵ American Academy of Dermatology Association, Schaumburg, Illinois.
⁶ Evans Dermatology Partners, Austin, Texas.
⁷ George Washington University School of Medicine, Washington, District of Columbia.
⁸ University of California, Irvine, California.
⁹ Division of Medicine, Department of Dermatology, University of Massachusetts, Boston, Massachusetts.
¹⁰ National Psoriasis Foundation, Portland, Oregon.
¹¹ Department of Dermatology, Duke University School of Medicine, Durham, North Carolina.
¹² Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, Miami, Florida.
¹³ Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
¹⁴ Department of Dermatology, University of Arkansas Medical Science Campus, Little Rock, Arkansas.
¹⁵ Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: babrod@comcast.net.

No abstract available

Keywords: coinsurances; drug pricing; formulary tiering; generic drugs; out-of-pocket costs; pharmacy benefit managers; prior authorizations.

MeSH terms